Isotretinoin Psychiatric Disorder Warning Strengthened
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised labeling for isotretinoin (Roche's Accutane and generics) suggests prescribers ask patients about psychiatric disorders prior to treatment initiation and continue that discourse throughout treatment